🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT01789229
Recruiting Observational

Establishment of a Tumor Bank for Tissue Samples

NCT01789229 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2003-09
Last updated
2023-03-23

Condition(s) studied

Ovarian NeoplasmsBreast NeoplasmsColorectal NeoplasmsNeoplasms of the Female GenitaliaLung NeoplasmsEndocrine Gland Neoplasms

Investigational drug(s) / intervention(s)

Tumor tissue collectionSampling of ascites and pleural effusionCollecting urine samplesCollecting saliva sampleCollecting sputumCollecting stool samplesLavage/Irrigation

Tumor tissue collection: Tissue sample is collected during therapeutic intervention by a medical doctor/surgeon. Frozen tissue sections are first transferred to Dept.of Pathology. Pathologist samples required tissue to obtain enough evidence for analysis/diagnosis. Rest tumor material with or without malignant cells is tranferred to the lab for Molecular Oncology of Prof.Zeillinger.

Sampling of ascites and pleural effusion: Samples of malignant ascites and/or malignant pleural effusion is only collected during therapeutic intervention from patients at inpatient care.

Collecting urine samples: Patient is asked to give a urine sample. Urine is collected in urine beaker.

Collecting saliva sample: Saliva sample is collected by spatula from the mouth cavity of the patient.

Collecting sputum: Patient is asked to produce sputum into a 50ml lab tube.

Collecting stool samples: Stool samples are collected prior to bowel preparation for colonoscopy. Device for sampling is provided to the patient.

Lavage/Irrigation: Irrigation liquid is collected during routine therapeutic or diagnostic procedure, e.g. lavage of the uterine cavity and fallopian tubes of women scheduled for surgery.

Study summary

Establishment of a tumor bank, consisting of tissue samples of tumor patients (benign and malign tumors) and healthy people as controls. The tissue samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tissue tumor bank.

This tumor bank for tissue samples, together with our tumorbank for blood samples (NCT01763125) combined constitute the entity "Tumorbank".

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Male/Female * Age 18 to 90 years max. * Just one current known malignant disease or just one current inflammatory disease Exclusion Criteria: * Inflammatory disease and malignant disease * multiple malignancies * multiple diseases * underage

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Medical University Vienna, Dptm. of Obstetrics & Gynaecology Vienna Austria Recruiting
University Hospitals Leuven - Department of Obstetrics and Gynaecology Leuven Belgium Completed
Charité University - Campus Virchow Chlinic Berlin Germany Active Not Recruiting

More Medical University of Vienna trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT01789229 on ClinicalTrials.gov ↗ ← All trials in Germany